Government |
Funding support for AKI research in hospital and community on AKI incidence, outcome and mortality |
|
Funding support for setting up AKI registries |
|
Recognition of natural hazards for AKI: water sanitation, flooding, venomous animals |
|
Recognition of AKI in common infections: malaria, dengue, leptospirosis, HIV, post-infectious hemolytic uremic syndrome |
|
Better obstetric care |
|
Collaboration with health care professionals on educating the public about AKI prevention |
Public |
Aware of the potential problems of AKI and avoid unsupervised, indiscriminate and long-term use of nephrotoxic drugs and natural substances |
General practitioners and physicians |
Awareness of patients at risk for AKI and situations contributing to AKI |
|
Aware of pre-renal causes of AKI and of the need for early and appropriate rehydration and hemodynamic optimization in hypovolemic patients |
|
Aware of natural and man-made nephrotoxin, nephrotoxic drugs, herbs and indigenous medicine |
|
Judicious use of nephrotoxic drugs and aware of potential drug interactions |
|
Early recognition of AKI and early referral to nephrologists |
Nephrologists |
Establish and implement common AKI diagnostic criteria and definitions for prevention, treatment and research |
|
Find new diagnostic tools including inexpensive technology and biomarkers for AKI diagnosis and monitoring |
|
Adapt renal replacement therapy to regional needs, technique and resource availability |